{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:31:38Z","timestamp":1787056298170,"version":"build-2736575974"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["No.YDZJ202601ZYTS393\u00a0\u00a0\u4e0d\u884c YDZJ202601ZYTS393"],"award-info":[{"award-number":["No.YDZJ202601ZYTS393\u00a0\u00a0\u4e0d\u884c YDZJ202601ZYTS393"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rhinovirus is the main pathogen causing common colds, acute exacerbations of asthma, chronic obstructive pulmonary disease and other respiratory diseases. Due to its numerous serotypes and the lack of common conserved viral targets, the development of traditional direct-acting antiviral drugs (DAAs) faces challenges. Host-targeting antivirals (HTAs), as an emerging strategy, provide a new approach to overcome this difficulty by interfering with the host cell factors or pathways necessary for viral replication. This review systematically presents the latest progress in host-targeted rhinovirus therapy by focusing on numerous host factors involved in rhinovirus invasion, attachment, biosynthesis, assembly and release, and immune regulation. Although the prospects are broad, the clinical transformation of this strategy still faces challenges such as safety, delivery efficiency, and individual differences. In conclusion, HTAs are expected to become a transformative treatment strategy for rhinovirus infection, especially for high-risk patient groups.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1892269","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:12:11Z","timestamp":1787055131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Broad-spectrum host-targeting antivirals for rhinovirus infections: mechanisms and future perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Wanru","family":"Shang","sequence":"first","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongye","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanzheng","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Center for Pathogen Biology and Infectious Diseases, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiration, Children\u2019s Medical Center, The First Hospital of Jilin University","place":["Changchun, China"]},{"name":"Center for Pathogen Biology and Infectious Diseases, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02412","article-title":"Rhinovirus biology, antigenic diversity, and advancements in the design of a human rhinovirus vaccine","volume":"8","author":"Stobart","year":"2017","journal-title":"Front Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.010","article-title":"Analysis of complete genome sequences of human rhinovirus","volume":"125","author":"Palmenberg","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.01.006","article-title":"Rhinovirus infections and their roles in asthma: etiology and exacerbations","volume":"10","author":"Jackson","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11882-016-0608-7","article-title":"Rhinoviruses and their receptors: implications for allergic disease","volume":"16","author":"Bochkov","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/CVI.00414-15","article-title":"Understanding the association of human rhinovirus with asthma","volume":"23","author":"Stone","year":"2016","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(17)30190-1","article-title":"Rhinovirus - not just the common cold","volume":"74","author":"Drysdale","year":"2017","journal-title":"J Infect"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12740","article-title":"Rhinovirus and preschool wheeze","volume":"28","author":"Stenberg-Hammar","year":"2017","journal-title":"Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24587","article-title":"Rhinovirus species and clinical characteristics in the first wheezing episode in children","volume":"88","author":"Turunen","year":"2016","journal-title":"J Med Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.0384","article-title":"Association of rhinovirus C bronchiolitis and immunoglobulin E sensitization during infancy with development of recurrent wheeze","volume":"173","author":"Hasegawa","year":"2019","journal-title":"JAMA Pediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.290","article-title":"Intranasal pirodavir (R77,975) treatment of rhinovirus colds","volume":"39","author":"Hayden","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2005.08.003","article-title":"Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril","volume":"68","author":"Ledford","year":"2005","journal-title":"Antiviral Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201500304","article-title":"Pyrazolopyrimidines: potent inhibitors targeting the capsid of rhino- and enteroviruses","volume":"10","author":"Makarov","year":"2015","journal-title":"ChemMedChem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00905-07","article-title":"In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease","volume":"51","author":"Binford","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00534-15","article-title":"The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir","volume":"59","author":"Lacroix","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1107\/S2052252525008929","article-title":"Structural insights into the antiviral efficacy of AG7404 against human rhinovirus 3C proteases","volume":"13","author":"Lee","year":"2026","journal-title":"IUCrJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry strategies toward host targeting antiviral agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med Res Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00203511","article-title":"Rhinovirus infections in infancy and early childhood","volume":"41","author":"Kieninger","year":"2013","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105840","article-title":"The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance","volume":"225","author":"Schreiber","year":"2024","journal-title":"Antiviral Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01896.x","article-title":"Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms","volume":"28","author":"Hofmann","year":"2008","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for treatment of subjects with respiratory syncytial virus-related infection: a systematic review and meta-analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116858","article-title":"Anti-HCV and Zika activities of ribavirin C-nucleosides analogues","volume":"68","author":"Gonzalez","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy760","article-title":"Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients","volume":"68","author":"Foolad","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic Malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(00)00223-9","article-title":"Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades","volume":"28","author":"Hubbard","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189187","article-title":"Intercellular adhesion molecule-1 (ICAM-1): from molecular functions to clinical applications in cancer investigation","volume":"1879","author":"Qian","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(88)90055-1","article-title":"Modification of experimental rhinovirus colds by receptor blockade","volume":"9","author":"Hayden","year":"1988","journal-title":"Antiviral Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/344070a0","article-title":"A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection","volume":"344","author":"Marlin","year":"1990","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.19.1797","article-title":"Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2022.01.002","article-title":"ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression","volume":"57","author":"Zhang","year":"2022","journal-title":"Dev Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003520","article-title":"An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation","volume":"9","author":"Traub","year":"2013","journal-title":"PloS Pathog"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111554","article-title":"Cilomilast modulates rhinovirus-induced airway epithelial ICAM-1 expression and IL-6, CXCL8 and CCL5 production","volume":"17","author":"Zhu","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.1.56","article-title":"Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4","volume":"129","author":"Rennard","year":"2006","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002309.pub5","article-title":"Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease","volume":"9","author":"Chong","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1761303","article-title":"Sex-specific adverse event profiles of PDE4 inhibitors: a comparative big-data pharmacovigilance study of apremilast, crisaborole, and roflumilast in FAERS (2004-2025)","volume":"17","author":"Huang","year":"2026","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S154198","article-title":"Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children","volume":"11","author":"Careddu","year":"2018","journal-title":"Int J Gen Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2007.09.004","article-title":"Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial","volume":"3","author":"Lizogub","year":"2007","journal-title":"Explore"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2012.09.022","article-title":"Can the Pelargonium sidoides root extract EPs\u00ae 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children","volume":"20","author":"Tahan","year":"2013","journal-title":"Phytomedicine Int J Phytother Phytopharm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210702","article-title":"Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells","volume":"14","author":"Roth","year":"2019","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311230","article-title":"EPs\u00ae 7630 stimulates tissue repair mechanisms and modifies tight junction protein expression in human airway epithelial cells","volume":"24","author":"Fang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2010.09.008","article-title":"Investigation of the influence of EPs\u00ae 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses","volume":"18","author":"Michaelis","year":"2011","journal-title":"Phytomedicine Int J Phytother Phytopharm"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.757666","article-title":"Antiviral and immunomodulatory effects of Pelargonium sidoides DC. root extract EPs\u00ae 7630 in SARS-CoV-2-infected human lung cells","volume":"12","author":"Papies","year":"2021","journal-title":"Front Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701214881","article-title":"The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions","volume":"39","author":"May","year":"2007","journal-title":"Ann Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1096\/fasebj.12.9.695","article-title":"Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro","volume":"12","author":"Marlovits","year":"1998","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0636","article-title":"Expression and folding of human very-low-density lipoprotein receptor fragments: neutralization capacity toward human rhinovirus HRV2","volume":"278","author":"Ronacher","year":"2000","journal-title":"Virology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020315","article-title":"ELISA-based assay for studying major and minor group rhinovirus-receptor interactions","volume":"8","author":"Pazderova","year":"2020","journal-title":"Vaccines"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093457","article-title":"Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs","volume":"9","author":"Davis","year":"2014","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2018.09.020","article-title":"Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7","volume":"36","author":"Lu","year":"2018","journal-title":"EBioMedicine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/prot.26140","article-title":"ACE2\u2010based decoy receptors for SARS coronavirus 2","volume":"89","author":"Jing","year":"2021","journal-title":"Proteins"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101301","article-title":"Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation","volume":"32","author":"Skeeters","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac032","article-title":"Defensins: defenders of human reproductive health","volume":"29","author":"Zhai","year":"2023","journal-title":"Hum Reprod Update"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116451","article-title":"Human \u03b2-defensins: The multi-functional natural peptide","volume":"227","author":"Zhao","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2013.09.038","article-title":"Antiviral mechanisms of human defensins","volume":"425","author":"Wilson","year":"2013","journal-title":"J Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175963","article-title":"Human \u03b2-defensin-2 production upon viral and bacterial co-infection is attenuated in COPD","volume":"12","author":"Arnason","year":"2017","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00024-25","article-title":"A branched peptide targets virus and host to block influenza virus and rhinovirus entry","volume":"69","author":"Meng","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201705-1021OC","article-title":"Cadherin-related family member 3 genetics and rhinovirus C respiratory illnesses","volume":"197","author":"B\u00f8nnelykke","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12858","article-title":"Reduced CDHR3 expression in children wheezing with rhinovirus","volume":"29","author":"Stenberg Hammar","year":"2018","journal-title":"Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.01.052","article-title":"Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations","volume":"144","author":"Everman","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104682","article-title":"AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice","volume":"93","author":"Keng","year":"2023","journal-title":"EBioMedicine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41420-024-02180-3","article-title":"Biological function of sialic acid and sialylation in human health and disease","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Death Discov"},{"key":"B63","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1073\/pnas.1606595113","article-title":"Atomic structure of a rhinovirus C, a virus species linked to severe childhood asthma","volume":"113","author":"Liu","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007477","article-title":"CDHR3 extracellular domains EC1-3 mediate rhinovirus C interaction with cells and as recombinant derivatives, are inhibitory to virus infection","volume":"14","author":"Watters","year":"2018","journal-title":"PloS Pathog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105945","article-title":"HEX17(Neumifil): An intranasal respiratory biotherapeutic with broad-acting antiviral activity","volume":"228","author":"Potter","year":"2024","journal-title":"Antiviral Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/v15030725","article-title":"Use of a preclinical natural transmission model to study antiviral effects of a carbohydrate-binding module therapy against SARS-CoV-2 in hamsters","volume":"15","author":"Knott","year":"2023","journal-title":"Viruses"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.11.6101-6107.2003","article-title":"Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating","volume":"77","author":"Xing","year":"2003","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/med.21940","article-title":"Therapeutic potential of salicylamide derivatives for combating viral infections","volume":"43","author":"Xu","year":"2023","journal-title":"Med Res Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PloS Pathog"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty","year":"2021","journal-title":"Viruses"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00110","article-title":"Drug repurposing of the anthelmintic niclosamide to treat multidrug-resistant leukemia","volume":"8","author":"Hamdoun","year":"2017","journal-title":"Front Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030248","article-title":"Niclosamide triggers non-canonical LC3 lipidation","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00764","article-title":"Defensins: A double-edged sword in host immunity","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1038\/s41467-020-17986-9","article-title":"A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.peptides.2018.04.006","article-title":"Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships","volume":"104","author":"Starr","year":"2018","journal-title":"Peptides"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm00801j","article-title":"Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity","volume":"8","author":"Liang","year":"2020","journal-title":"Biomater Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1243OC","article-title":"Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice","volume":"177","author":"Newcomb","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010159","article-title":"Rhinovirus C replication is associated with the endoplasmic reticulum and triggers cytopathic effects in an in vitro model of human airway epithelium","volume":"18","author":"Gagliardi","year":"2022","journal-title":"PloS Pathog"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201796687","article-title":"Sterol transfer, PI4P consumption, and control of membrane lipid order by endogenous OSBP","volume":"36","author":"Mesmin","year":"2017","journal-title":"EMBO J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949876","article-title":"Another hijack! Some enteroviruses co-opt the c10orf76\/PI4KB complex for their own good","volume":"21","author":"Voilquin","year":"2020","journal-title":"EMBO Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.054","article-title":"Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein","volume":"10","author":"Strating","year":"2015","journal-title":"Cell Rep"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/srep23110","article-title":"Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model","volume":"6","author":"Shim","year":"2016","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00128.x","article-title":"Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy","volume":"28","author":"NoorZurani","year":"2009","journal-title":"Drug Alcohol Rev"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.655808","article-title":"Case report: QT prolongation and abortive sudden death observed in an 85-year-old female patient with advanced lung cancer treated with tyrosine kinase inhibitor osimertinib","volume":"8","author":"Kondo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12081619","article-title":"QTc interval prolongation as an adverse event of azole antifungal drugs: Case report and literature review","volume":"12","author":"Kitaya","year":"2024","journal-title":"Microorganisms"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16081102","article-title":"Electrospraying as a means of loading itraconazole into mesoporous silica for enhanced dissolution","volume":"16","author":"Volitaki","year":"2024","journal-title":"Pharmaceutics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.01.003","article-title":"27-hydroxycholesterol: The first identified endogenous SERM","volume":"22","author":"Umetani","year":"2011","journal-title":"Trends Endocrinol Metab TEM"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2019.08.031","article-title":"Modulation of cell proteome by 25-hydroxycholesterol and 27-hydroxycholesterol: A link between cholesterol metabolism and antiviral defense","volume":"149","author":"Civra","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03546-12","article-title":"Oxysterol-binding protein family I is the target of minor enviroxime-like compounds","volume":"87","author":"Arita","year":"2013","journal-title":"J Virol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105368","article-title":"27-hydroxycholesterol inhibits rhinovirus replication in vitro and on human nasal and bronchial histocultures without selecting viral resistant variants","volume":"204","author":"Civra","year":"2022","journal-title":"Antiviral Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/biom2010076","article-title":"Oxysterols and their cellular effectors","volume":"2","author":"Olkkonen","year":"2012","journal-title":"Biomolecules"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00482.2018","article-title":"Pharmacological activation of liver X receptor during cigarette smoke exposure adversely affects alveolar macrophages and pulmonary surfactant homeostasis","volume":"316","author":"Jubinville","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.1c00147","article-title":"Animal fatty acid synthase: A chemical nanofactory","volume":"121","author":"Paiva","year":"2021","journal-title":"Chem Rev"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144648","article-title":"Direct inhibition of cellular fatty acid synthase impairs replication of respiratory syncytial virus and other respiratory viruses","volume":"10","author":"Ohol","year":"2015","journal-title":"PloS One"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.04.002","article-title":"New\u201d hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis","volume":"1","author":"Chakravarthy","year":"2005","journal-title":"Cell Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: The role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15712","article-title":"Statins attenuate antiviral IFN-\u03b2 and ISG expression via inhibition of IRF3 and JAK\/STAT signaling in poly(I:C)-treated hyperlipidemic mice and macrophages","volume":"288","author":"Koike","year":"2021","journal-title":"FEBS J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0713413","article-title":"Simvastatin attenuates rhinovirus-induced interferon and CXCL10 secretion from monocytic cells in vitro","volume":"95","author":"Wickert","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s42003-021-02754-2","article-title":"Statin-mediated disruption of Rho GTPase prenylation and activity inhibits respiratory syncytial virus infection","volume":"4","author":"Malhi","year":"2021","journal-title":"Commun Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-european atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1093\/nar\/gkw271","article-title":"The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold","volume":"44","author":"Knott","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1280","article-title":"PSF: nuclear busy-body or nuclear facilitator","volume":"6","author":"Yarosh","year":"2015","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007277","article-title":"Exploitation of nuclear functions by human rhinovirus, a cytoplasmic RNA virus","volume":"14","author":"Flather","year":"2018","journal-title":"PloS Pathog"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.10.012","article-title":"Translation\u2014a tug of war during viral infection","volume":"83","author":"Rozman","year":"2023","journal-title":"Mol Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41594-023-01196-0","article-title":"The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A","volume":"31","author":"Querido","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1039\/d0np00024h","article-title":"Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds","volume":"38","author":"Schulz","year":"2021","journal-title":"Nat Prod Rep"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030540","article-title":"Targeting the DEAD-Box RNA helicase eIF4A with rocaglates-a pan-antiviral strategy for minimizing the impact of future RNA virus pandemics","volume":"9","author":"Taroncher-Oldenburg","year":"2021","journal-title":"Microorganisms"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.12.010","article-title":"Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses","volume":"150","author":"M\u00fcller","year":"2018","journal-title":"Antiviral Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-26765-4_1","article-title":"Coronavirus genome structure and replication","volume":"287","author":"Brian","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2024.2433830","article-title":"Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition","volume":"21","author":"Wu","year":"2024","journal-title":"RNA Biol"},{"key":"B112","volume-title":"A Phase 1b Study of Zotatifin for the Treatment of Mild to Moderate COVID (PROPEL)","author":"Malech","year":"2023"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41467-025-57094-0","article-title":"The CXCL8\/MAPK\/hnRNP-K axis enables susceptibility to infection by EV-D68, rhinovirus, and influenza virus in vitro","volume":"16","author":"Yang","year":"2025","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp4625","article-title":"MEK1\/2 inhibitors suppress pathological \u03b1-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson\u2019s disease","volume":"17","author":"Wang","year":"2025","journal-title":"Sci Transl Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102237","article-title":"Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trial","volume":"65","author":"Rohde","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.70326","article-title":"Cutaneous adverse drug reactions associated with BRAF and MEK inhibitors: a real-world analysis of WHO pharmacovigilance data","volume":"120","author":"Sauer","year":"2026","journal-title":"Clin Pharmacol Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113354","article-title":"Long-term outcomes and persistent toxicities following BRAF\/MEK inhibitor therapy for advanced melanoma","volume":"194","author":"Goodman","year":"2023","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.08.005","article-title":"Structural basis for regulation of phosphoinositide kinases and their involvement in human disease","volume":"71","author":"Burke","year":"2018","journal-title":"Mol Cell"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2148-11-4","article-title":"Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery","volume":"11","author":"Brown","year":"2011","journal-title":"BMC Evol Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00582-5","article-title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","volume":"22","author":"Burke","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00303-13","article-title":"Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo","volume":"57","author":"Spickler","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02309-06","article-title":"Rhinovirus activates interleukin-8 expression via a Src\/p110beta phosphatidylinositol 3-kinase\/Akt pathway in human airway epithelial cells","volume":"81","author":"Bentley","year":"2007","journal-title":"J Virol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116055","article-title":"Phosphoinositide-3 kinase inhibition modulates responses to rhinovirus by mechanisms that are predominantly independent of autophagy","volume":"9","author":"Ismail","year":"2014","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102984","article-title":"Therapeutic mTOR blockade in systemic autoimmunity: implications for antiviral immunity and extension of lifespan","volume":"20","author":"Geier","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B126","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(23)00258-1","article-title":"Targeting ageing with rapamycin and its derivatives in humans: a systematic review","volume":"5","author":"Lee","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107505","article-title":"Enterovirus A71-induced glycolysis is essential for viral replication by activating PI3K\/Akt pathway","volume":"203","author":"Li","year":"2025","journal-title":"Microb Pathog"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800525115","article-title":"Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication","volume":"115","author":"Gualdoni","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107069","article-title":"Safety, tolerability, and pharmacokinetics of intranasal 2-deoxy-D-glucose in normal healthy volunteers: a randomized, double-blind, placebo-controlled, single and multiple ascending dose phase 1 study","volume":"209","author":"Bischof","year":"2025","journal-title":"Eur J Pharm Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001178","article-title":"Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium","volume":"6","author":"Slater","year":"2010","journal-title":"PloS Pathog"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12931-019-1120-0","article-title":"Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells","volume":"20","author":"Warner","year":"2019","journal-title":"Respir Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41467-023-37470-4","article-title":"Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19","volume":"14","author":"Radzikowska","year":"2023","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000309","article-title":"Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis","volume":"132","author":"Jin","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0245","article-title":"Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage","volume":"11","author":"Miljkovic-Licina","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313052","article-title":"Microglia-derived olfactomedin-like 3 promotes pro-tumorigenic microglial function and Malignant features of glioma cells","volume":"22","author":"Toedebusch","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B138","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13059-021-02513-w","article-title":"Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist","volume":"22","author":"Mei","year":"2021","journal-title":"Genome Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antiviral Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00168-19","article-title":"Host-directed antiviral therapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"B141","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13755-025-00370-6","article-title":"CF-DTI: coarse-to-fine feature extraction for enhanced drug-target interaction prediction","volume":"13","author":"Qian","year":"2025","journal-title":"Health Inf Sci Syst"},{"key":"B142","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41596-018-0097-3","article-title":"Systemic AAV vectors for widespread and targeted gene delivery in rodents","volume":"14","author":"Challis","year":"2019","journal-title":"Nat Protoc"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1039\/c7bm00584a","article-title":"Peptides, polypeptides and peptide-polymer hybrids as nucleic acid carriers","volume":"5","author":"Ahmed","year":"2017","journal-title":"Biomater Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cclet.2021.08.090","article-title":"Macrophage-targeted nanomedicine for chronic diseases immunotherapy","volume":"33","author":"Song","year":"2022","journal-title":"Chin Chem Lett"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1039\/d2tb02455a","article-title":"Optimal delivery strategies for nanoparticle-mediated mRNA delivery","volume":"11","author":"Li","year":"2023","journal-title":"J Mater Chem B"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat Rev Genet"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c05376","article-title":"Predicting in vitro and in vivo anti-SARS-CoV-2 activities of antivirals by intracellular bioavailability and biochemical activity","volume":"7","author":"Zhang","year":"2022","journal-title":"ACS Omega"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2026.118642","article-title":"Rational design of dual PB2\/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects","volume":"307","author":"Yang","year":"2026","journal-title":"Eur J Med Chem"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.07.012","article-title":"Adeno-associated viral vector integration: implications for long-term efficacy and safety","volume":"22","author":"Batty","year":"2024","journal-title":"J Thromb Haemost JTH"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/s0065-3527(08)60375-9","article-title":"Clinical virology of rhinoviruses","volume":"54","author":"Hendley","year":"1999","journal-title":"Adv Virus Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S255211","article-title":"Experimental antiviral therapeutic studies for human rhinovirus infections","volume":"13","author":"Coultas","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2193","article-title":"Rhinovirus and asthma: challenges and opportunities","volume":"31","author":"Ortega","year":"2021","journal-title":"Rev Med Virol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000191507.48481.10","article-title":"Host determinants of antiretroviral drug activity","volume":"18","author":"Boffito","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092231","article-title":"Investigating tacrolimus disposition in paediatric patients with a physiologically based pharmacokinetic model incorporating CYP3A4 ontogeny, mechanistic absorption and red blood cell binding","volume":"15","author":"Van der Veken","year":"2023","journal-title":"Pharmaceutics"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1678343","article-title":"Epidemiological shift and clinical characteristics of rhinovirus genotypes in acute respiratory tract infection cases in Kunming, China, from 2019 to 2023","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003712","article-title":"Dynamic balance of the lung microbiome in health and respiratory diseases","volume":"139","author":"Wang","year":"2026","journal-title":"Chin Med J (Engl)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1892269\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:12:14Z","timestamp":1787055134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1892269\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":158,"alternative-id":["10.3389\/fimmu.2026.1892269"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1892269","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1892269"}}